Sherlock Biosciences announces discovery of novel CRISPR-Cas enzymes, enabling simple multiplex diagnostic solutions
Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics